These findings indicate that overexpression of a single target of HuR (e.g., CYCS) may be insufficient to rescue effect of HuR cKO in influencing NAFLD pathogenesis. The gene discussed is ELAVL1; the disease is metabolic dysfunction-associated steatotic liver disease.